Target intelligence / Profile preview

Other tyrosine protein kinases

Molecular classification
Enzyme, Kinase, Tyrosine protein kinase
01

Overview

The term "Other tyrosine protein kinases" refers to a broad and heterogeneous classification of enzymes that facilitate the transfer of a phosphate group from ATP to specific tyrosine residues on substrate proteins (UniProt, 2023). This grouping is typically used in pharmacological and genomic databases to categorize tyrosine kinases that do not fall into the primary established families such as Src, Abl, or the various receptor tyrosine kinase subfamilies (Manning et al., 2002). These enzymes are essential components of cellular signal transduction pathways, regulating critical processes including cell growth, differentiation, and survival (NCBI, 2024). Dysregulation, often through mutation or overexpression, of these kinases is a primary driver in many types of cancer and inflammatory diseases (PubMed, 2023). While many small-molecule inhibitors like imatinib and dasatinib target specific tyrosine kinases, they often exhibit activity across multiple members of this broad class due to the conserved nature of the ATP-binding pocket (PubChem, 2024). Consequently, this category represents a collection of potential therapeutic targets rather than a single, discrete molecular entity.

Other names
Miscellaneous tyrosine kinasesUnclassified tyrosine kinasesNon-receptor tyrosine kinases (subset)Other TK group
02

Mechanism of action

Inhibition of the catalytic activity of the kinase domain, typically by competing with ATP for the binding site, thereby preventing the phosphorylation of substrate proteins and interrupting downstream signaling pathways (PubChem, 2024).

03

Biological functions

Signal transductionCell proliferationCell differentiationApoptosisCell adhesion
04

Disease associations

CancerInflammationAutoimmune disease
05

Safety considerations

Off-target toxicityCardiotoxicityGastrointestinal distressMyelosuppression
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

Kinase domain mutationsProtein expression levelsPhosphorylation statusGene fusions

Beyond the preview

Go deeper on Other tyrosine protein kinases.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Other tyrosine protein kinases.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call